Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Amy McBride WendellDirector | AxogenAXGN | Open-market sale | 05/08 | 05/12 | 1,647 sh | $42.60 | $70,162.2 | −1.7% |
John JohnsonDirector | AxogenAXGN | Open-market sale | 05/07 | 05/08 | 11,050 sh | $43.26 | $478,023 | −100.0% |
Kathy Johnson WeilerDirector | AxogenAXGN | Open-market sale | 05/07 | 05/08 | 16,344 sh | $44.09 | $720,606.96 | −100.0% |
Jens KempChief Marketing Officer | AxogenAXGN | Open-market sale | 05/07 | 05/08 | 4,000 sh | $43.44 | $173,760 | −5.2% |
AxogenAXGN | Open-market sale | 05/07 | 05/08 | 1,051 sh2 trades | $43.67avg. | $45,897.17 | −1.6% | |
Doris QuackenbushSales VP | AxogenAXGN | Open-market sale | 05/07 | 05/08 | 3,878 sh | $43.51 | $168,731.78 | −4.0% |
Erick Wayne DeVinneyChief Innovation Officer | AxogenAXGN | Open-market sale | 03/16 | 03/18 | 5,221 sh | $32.84 | $171,457.64 | −1.9% |
AxogenAXGN | Open-market sale | 25/12/16 | 25/12/17 | 43,684 sh3 trades | $29.31avg. | $1,280,378.04 | −31.8% | |
AxogenAXGN | Open-market sale | 25/12/16 | 25/12/17 | 46,653 sh3 trades | $29.55avg. | $1,378,596.15 | −100.0% | |
AxogenAXGN | Open-market sale | 25/12/15 | 25/12/17 | 14,812 sh | $29.86 | $442,286.32 | −32.1% | |
Marc A. BeganEVP & General Counsel | AxogenAXGN | Open-market sale | 25/12/11 | 25/12/12 | 13,222 sh | $30.00 | $396,660 | −42.0% |
AxogenAXGN | Open-market sale | 25/12/10 | 25/12/12 | 25,000 sh | $30.00 | $750,000 | −28.2% | |
Paul ThomasDirector | AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 21,399 sh | $29.61 | $633,624.39 | −61.3% |
AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 61,463 sh | $31.21 | $1,918,260.23 | −41.0% | |
AxogenAXGN | Open-market sale | 25/12/08–25/12/09 | 25/12/10 | 45,379 sh4 trades | $30.64avg. | $1,390,313.82 | −100.0% | |
Erick Wayne DeVinneyChief Innovation Officer | AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 19,517 sh | $31.21 | $609,125.57 | −7.5% |
Marc A. BeganEVP & General Counsel | AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 9,278 sh | $31.21 | $289,566.38 | −22.7% |
AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 25,108 sh2 trades | $30.98avg. | $777,845.84 | −100.0% | |
Jens KempChief Marketing Officer | AxogenAXGN | Open-market sale | 25/12/09 | 25/12/10 | 8,156 sh | $31.21 | $254,548.76 | −15.1% |
AxogenAXGN | Open-market sale | 25/12/08 | 25/12/10 | 14,387 sh2 trades | $31.56avg. | $454,053.72 | −31.4% |